Bullock Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$543K Buy
4,333
+17
+0.4% +$1.99K 0.24% 97
2026
Q1
$522K Buy
4,316
+17
+0.4% +$1.96K 0.26% 90
2025
Q4
$453K Sell
4,299
-1
-0% -$94 0.22% 95
2025
Q3
$388K Buy
4,300
+470
+12% +$38.7K 0.19% 107
2025
Q2
$313K Buy
3,830
+18
+0.5% +$1.43K 0.17% 112
2025
Q1
$332K Sell
3,812
-107
-3% -$9.99K 0.19% 108
2024
Q4
$390K Sell
3,919
-478
-11% -$49.3K 0.23% 95
2024
Q3
$505K Sell
4,397
-199
-4% -$23.6K 0.3% 80
2024
Q2
$588K Sell
4,596
-441
-9% -$56.8K 0.39% 67
2024
Q1
$660K Buy
+5,037
New +$621K 0.44% 60

Other funds holding MRK

Bullock Wealth Management's MRK Position: Q2 2026 in Review

Bullock Wealth Management increased its Merck (MRK) stake by 0.39% in Q2 2026, buying an estimated $1.99K and bringing the position to 4,333 shares worth $543K. The position accounts for 0.24% of the portfolio, ranked #97.

Bullock Wealth Management first reported a position in MRK in Q1 2024 and has held it in 10 quarters since. The position peaked at $660K in Q1 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Bullock Wealth Management held 4,333 shares of Merck worth $543K as of Q2 2026.
  • Bullock Wealth Management bought 17 Merck shares in Q2 2026, an estimated $1.99K.
  • Merck made up 0.24% of Bullock Wealth Management's portfolio in Q2 2026, its #97 holding.
  • Bullock Wealth Management first reported a position in Merck in Q1 2024 and has held it in 10 quarters since.
  • Bullock Wealth Management's Merck position peaked at $660K in Q1 2024.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Bullock Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.